Sabrina Paganoni, MD, PhD: A Combination Approach to ALS

(3:6)

Sabrina Paganoni, MD, PhD: AMX0035 and the Future of ALS Care

(2:4)

2020 Symposium on ALS - Keynote Address: Sabrina Paganoni, MD, PhD - The HEALEY ALS Platform Trial

(1:8:22)

Sabrina Paganoni, MD, PhD: AMX0035 Phase 2 Performance in ALS

(3:2)

Sabrina Paganoni, MD, PhD: AMX0035 and the Current ALS Treatment Landscape

(2:14)

SPF Virtual Conference Series #2 with Dr.Sabrina Paganoni

(1:4:6)

2022 Annual ALS ONE Research Symposium: Dr. Sabrina Paganoni/EAP's \u0026 ACT FOR ALS Updates.

(19:44)

Sabrina Paganoni, MD, PhD: Collaboration in the CENTAUR Trial of AMX0035 in ALS

(2:54)

7th Annual ALS ONE Research Symposium: Day 1 – Keynote Speaker: Dr. Sabrina Paganoni, MD, PhD of MGH

(21:30)

Sabrina Paganoni, MD, PhD: CENTAUR Trial Open-Label Extension in ALS

(2:16)

Newsflash: Amylyx: RELYVRIO by Sabrina Paganoni

(59:53)

Current Research \u0026 Clinical Trial Updates with Dr. Sabrina Paganoni MD, PhD

(55:21)

Sabrina Paganoni, MD, PhD: Takeaways from the CENTAUR Trial of AMX0035

(2:4)

2022 Annual ALS ONE Research Symposium: Dr. Sabrina Paganoni/Platform Trial Update

(25:59)

MDA Facebook Live #ALS Care \u0026 Research Updates Dr Sabrina Paganoni, Ph D

(34)

Sabrina Paganoni, MD, PhD Discussion on HEALEY ALS Platform Trial and AMX0035 Help \u0026 Hope 2021

(29:4)

2017 \

(31:13)

Neurology Grand Rounds – Changing the Paradigm for ALS clinical trialsi

(1:16)

MDA Facebook Live: #ALS Care \u0026 Research Updates Featuring Dr. Harms \u0026 Dr. Sabrina Paganoni, Ph.D.

(25:32)

MDA Facebook Live Event: Care and Research Updates on #ALS, Today - Dr. Paganoni

(39)